[Federal Register: November 23, 2005 (Volume 70, Number 225)]
[Notices]
[Page 70860-70861]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23no05-112]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Center for Substance Abuse Prevention; Notice of Meeting
Pursuant to Pub. L. 92-463, notice is hereby given of the meeting
of the Substance Abuse and Mental Health Services Administration
(SAMHSA) Drug Testing Advisory Board on December 13-14, 2005.
A portion of the meeting will be open and will include a roll call,
general announcements, a Department of Health and Human Services drug
testing program update, a Department of Transportation drug testing
program update, and a Nuclear Regulatory Commission drug testing
program update.
Attendance by the public will be limited to space available. Public
comments are welcome. Please communicate with the individual listed
below as contact to make arrangements to comment or to request special
accommodations for persons with disabilities.
The Board will also meet to develop the final revisions to the
proposed Mandatory Guidelines for Federal Workplace Drug Testing
Programs that were published in the Federal Register on April 13, 2004
(69 FR 19673) and to discuss Federal agency specimen results, medical
review officer interpretations, laboratory inspection issues, and
analytical instrumentation issues. This meeting will be conducted in
closed session since discussing these issues in open session will
significantly frustrate the Department's ability to develop the
revisions to the Mandatory Guidelines or to disclose information of a
personal nature where disclosure would constitute an unwarranted
invasion of personal privacy. The HHS Office of General Counsel made
the determination that such matters are protected by exemptions (6) and
9(B) of section 552b(c) of title 5 U.S.C. and therefore may be closed
to the public.
To facilitate entering the building for the open session, public
attendees are
[[Page 70861]]
required to contact Mrs. Giselle Hersh, Division of Workplace Programs,
1 Choke Cherry Road, Room 2-1042, Rockville, MD 20857, 240-276-2605
(telephone) or by e-mail to Giselle.Hersh@samhsa.hhs.gov.
Substantive program information and a roster of Board members may
be obtained by accessing the SAMHSA workplace Web site (http://workplace.samhsa.gov
) or communicating with the contact whose name and
telephone number are listed below. The transcript for the open session
will be available on the SAMHSA workplace Web site as soon as possible
after the meeting.
Committee Name: Substance Abuse and Mental Health Services
Administration Drug Testing Advisory Board.
Meeting Date: December 13-14, 2005.
Place: SAMHSA Building, Sugarloaf Conference Room, 1 Choke Cherry
Road, Rockville, Maryland 20850.
Type: Open: December 13, 2005; 8:30 a.m.-10:30 a.m.
Closed: December 13, 2005; 10:30 a.m.-4:30 p.m.
Closed: December 14, 2005; 8:30 a.m.-Noon.
Contact: Donna M. Bush, Ph.D., Executive Secretary, 1 Choke Cherry
Road, Room 2-1033, Rockville, Maryland 20857, 240-276-2600 (telephone)
and 240-276-2610 (fax), e-mail: Donna.Bush@samhsa.hhs.gov.
Dated: November 17, 2005.
Robert E. Stephenson,
Acting Committee Management Officer, Substance Abuse and Mental Health
Services Administration.
[FR Doc. 05-23155 Filed 11-22-05; 8:45 am]
BILLING CODE 4162-20-P